Abstract
Once the diagnosis of osteoporosis is established, a plan of medical intervention should be formulated, taking into account the severity of the osteoporosis, any contributory causes, other medical conditions which may influence treatment, and the circumstances of the patient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Black DM, Cummings SR, Karpf DB, Cauley JA, Thmpson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Tomer JC, Quandt SA, Reiss TF, Ensrud KE. (1996) Randomised trial of effect of alendronate on risk of fracture in women withexisting vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348(9041): 1535–41.
Chapuy MC, Arlot ME, Duboeuf F, Bran J, Crouzet B, Arnaud S, Delmas P, Meunier PH. (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Eng J Med 327(No.23): 1637–1641.
Cummings SR. (1991) Evaluation of benefits and risks of postmenopausal hormone therapy. Am J Med 91(5B):14S–18S.
Dawson-Hughes B, Dallai GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. (1990) A conrolled trial of the effect of calcium supplementation on bone density inpostmenopausal women. N Eng J Med 323:878–883.
Devogelaer JP, Broil H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ,Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W. (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18(2): 141–50.
Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Arnaud C. (1996) A controlled trial of raloxifene (LY139481) HCI: Impact on bone turnover and serum lipidprofile in healthy postmenopausal women. J Bone Miner Res 11(6):835–42.
Francis RM, Peacock M, Taylor GA, et al. (1984) Calcium malabsorption in elderly women with vertebral fractures: Evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci 66:103–107.
Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. (1979) Intestinal Ca absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 64:729–736.
Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51(6):1359–1364.
Garnero P, Delmas PD. (1996) New developments in biochemical markers for osteoporosis. Calcif Tiss Int 59 Suppl 1:S2–9.
Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, LicataAA, Chesnut CH. (1993) Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 95(6):557–67.
Lufkin EG, Warmer HW, OÃFallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL. (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117 (1):1–9.
Mattson LA, Cullberg G, Samsioe G. (1982) Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Maturitas 95–102.
McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. (1996) Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab 81(5):1699–703.
Meunier PJ, Sebert J-L, Reginster J-Y, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A, Barry S, Evreux J-C, Avouac B, Marchandise X, FAVOStudy Group, (in press) Flouride salts do not better prevent vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: The FAVOStudy. Osteoporosis Int
Need AG, Horowitz M, Philcox JC, Nordin BC. (1985) 1,25-Dihydroxycholecalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover. Mineral & Electrolyte Metabolism ll(l):35–40.
Nordin BEC, Need AG, Morris HA, Horowitz M, Robertson WG. (1991) Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab 72:401–407.
Overgaard K, Hansen MA, Jensen SB, Christiansen C. (1992) Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 305(6853):556–61.
Recker RR, Hinders S, Davies KM, Heaney RP, Stegman MR, Lappe JM, Kimmel DB. (1996) Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11(12):1961–6.
Riggs BL, Hodgson SF, O’Fallon WM, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ. (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802–809.
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. (1991) Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325(11):756–762.
Thiebaud D, Burckhardt P, Malchior J, Eckert P, Jacquet AF Schnyder P, Gobelet C. (1994) Two years effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occuring in the postmenopause. Osteoporosis Int 4:76–83.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag London Limited
About this chapter
Cite this chapter
Bone, H.G. (1998). Treatment of Osteoporosis. In: Geusens, P. (eds) Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-3382-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3382-7_20
Publisher Name: Springer, London
Print ISBN: 978-3-540-76223-2
Online ISBN: 978-1-4471-3382-7
eBook Packages: Springer Book Archive